Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

No need to treat most functional gastric disorders in infants

Most functional gastrointestinal problems in infants...

High loperamide doses linked to serious cardiac reactions

Cardiac events including QT prolongation, torsades...

NICE approves first treatment for IBS with diarrhoea

Eluxadoline (Truberzi) can now be prescribed routinely...

Methotrexate pen approved to treat Crohn's disease

NICE approves alternative biologic for Crohn's disease

Patients with moderate to severe Crohn's disease should...

Eluxadoline: first treatment option for IBS patients with diarrhoea

Truberzi (eluxadoline) is a new orally administered...

Cardiac warning for anticholinergic injection

Hyoscine butylbromide (Buscopan) injection should be...

New biologic option for Crohn's disease

Patients with moderately to severely active Crohn's...

Summaries of NICE bowel disease guidance published by MIMS

GPs treating patients with inflammatory bowel disease...

Movicol now available in ready-to-use sachets

Ferric maltol: new iron therapy for patients with inflammatory bowel disease

Feraccru (ferric maltol) is licensed for the treatment...

Updated MIMS summary of H. pylori treatment regimens

The popular quick-reference MIMS summary of NICE guidance...

Proton pump inhibitors associated with low risk of cutaneous lupus

Proton pump inhibitors (PPIs) are associated with very...

Naloxone derivative launched for opioid-induced constipation

Naloxegol (Moventig) provides a new option for the...

NICE approves vedolizumab for Crohn's disease

The integrin inhibitor vedolizumab (Entyvio) has been...

Broader use for opioid-induced constipation treatment

New constipation treatment receives NICE approval

The constipation treatment naloxegol (Moventig) will...

Women-only constipation treatment now licensed in men

Prescribers can now consider the 5HT4 agonist prucalopride...

Ulcerative colitis treatment recommended by NICE

Vedolizumab (Entyvio) has been accepted by NICE for...